Eculizumab is effective for Budd-Chiari syndrome with paroxysmal nocturnal hemoglobinuria

Kentaro Yoshinaga

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-31 Thromabosis

Sat. Oct 13, 2018 5:10 PM - 5:50 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Chair: Hideo Wada (Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine)

[PS2-31-3] Eculizumab is effective for Budd-Chiari syndrome with paroxysmal nocturnal hemoglobinuria

Kentaro Yoshinaga¹, Masayuki Shiseki¹, Midori Ishiyama¹, Akihito Shinohara¹, Hiroshi Kazama¹, Shotaro Hagiwara¹, Naoki Mori¹, Tomomi Kogiso², Shuji Sakai³, Katsutoshi Tokushige², Junji Tanaka¹ (1.Dept Hematol., Tokyo Women's Univ. Tokyo, Japan, 2.Institute of Gastroenterology, Dept. internal medicine, Tokyo Women's Medical Univ., 3.Dept. Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical Univ.)

Abstract password authentication.
Password is written on a program and abstract book.